Role of electroconvulsive therapy in patients with clozapine-refractory schizophrenia

Schizophr Res. 2024 Jul:269:130-131. doi: 10.1016/j.schres.2024.05.013. Epub 2024 May 21.

Authors

Matej Markota¹, Paul E Croarkin², Melanie T Gentry², Jonathan G Leung³

Affiliations

¹ Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. Electronic address: markota.matej@mayo.edu.
² Department of Psychiatry and Psychology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
³ Department of Pharmacy, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

PMID: 38776722
DOI: 10.1016/j.schres.2024.05.013

No abstract available

Publication types

Letter

MeSH terms

Adult
Antipsychotic Agents*
Clozapine* / therapeutic use
Electroconvulsive Therapy*
Female
Humans
Male
Middle Aged
Schizophrenia / drug therapy
Schizophrenia / therapy
Schizophrenia, Treatment-Resistant* / drug therapy
Schizophrenia, Treatment-Resistant* / therapy

Substances

Clozapine
Antipsychotic Agents